Relevant to: All Medicare Advantage Organizations (MAOs) and Prescription Drug Plan Sponsors (PDPs)
The Centers for Medicare & Medicaid Services (CMS), in collaboration with the Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC), conducted a National Audit of Medicare Part D Payments for Nuedexta prescribed without a documented medically accepted indication (MAI) under the Medicare Part A, Part B, or Part C programs.
